There is no clinical evidence of consequences after methylene blue chromoendoscopy
Authors:
- M. Dinis-RibeiroMDM. Dinis-Ribeiro
- L. Moreira-DiasLML. Moreira-Dias
- 30 June 2008
- journal article
- other
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 67 (7) , 1209
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- ChromoendoscopyGastrointestinal Endoscopy, 2007
- Chromoscopy-Guided Endomicroscopy Increases the Diagnostic Yield of Intraepithelial Neoplasia in Ulcerative ColitisGastroenterology, 2007
- Feasibility and cost‐effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow‐up of patients with atrophic chronic gastritis and intestinal metaplasiaJournal of Gastroenterology and Hepatology, 2007
- Methylene blue but not indigo carmine causes DNA damage to colonocytes in vitro and in vivo at concentrations used in clinical chromoendoscopyGut, 2006
- Chromoendoscopy with methylene blue and the risk of DNA damageGastroenterology, 2004
- A follow up model for patients with atrophic chronic gastritis and intestinal metaplasiaJournal of Clinical Pathology, 2004
- Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasiaGastrointestinal Endoscopy, 2003
- Methylene blue selectively stains intestinal metaplasia in Barrett's esophagusGastrointestinal Endoscopy, 1996
- Endoscopic Diagnosis of Intestinal Metaplasia in Canada and JapanJournal of Clinical Gastroenterology, 1981